Table of Contents 1 Study Coverage 1.1 Ophthalmic Therapeutic Drugs Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type 1.4.2 Anti-inflammatory Drugs 1.4.3 Anti-infective Drugs 1.4.4 Anti-glaucoma Drugs 1.4.5 Anti-allergy Drugs 1.4.6 Anti-VEGF Agents 1.4.7 Others 1.5 Market by Application 1.5.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Online Pharmacies 1.5.4 Independent Pharmacies & Drug Stores 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Ophthalmic Therapeutic Drugs Market Size 2.1.1 Global Ophthalmic Therapeutic Drugs Revenue 2016-2025 2.1.2 Global Ophthalmic Therapeutic Drugs Sales 2016-2025 2.2 Ophthalmic Therapeutic Drugs Growth Rate by Regions 2.2.1 Global Ophthalmic Therapeutic Drugs Sales by Regions 2.2.2 Global Ophthalmic Therapeutic Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Ophthalmic Therapeutic Drugs Sales by Manufacturers 3.1.1 Ophthalmic Therapeutic Drugs Sales by Manufacturers 3.1.2 Ophthalmic Therapeutic Drugs Sales Market Share by Manufacturers 3.1.3 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Ophthalmic Therapeutic Drugs Revenue by Manufacturers 3.2.1 Ophthalmic Therapeutic Drugs Revenue by Manufacturers (2016-2018) 3.2.2 Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers (2016-2018) 3.3 Ophthalmic Therapeutic Drugs Price by Manufacturers 3.4 Ophthalmic Therapeutic Drugs Manufacturing Base Distribution, Product Types 3.4.1 Ophthalmic Therapeutic Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Ophthalmic Therapeutic Drugs Product Category 3.4.3 Date of International Manufacturers Enter into Ophthalmic Therapeutic Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Ophthalmic Therapeutic Drugs Sales by Type 4.2 Global Ophthalmic Therapeutic Drugs Revenue by Type 4.3 Ophthalmic Therapeutic Drugs Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Ophthalmic Therapeutic Drugs Breakdown Data by Application 6 North America 6.1 North America Ophthalmic Therapeutic Drugs by Countries 6.1.1 North America Ophthalmic Therapeutic Drugs Sales by Countries 6.1.2 North America Ophthalmic Therapeutic Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Ophthalmic Therapeutic Drugs by Type 6.3 North America Ophthalmic Therapeutic Drugs by Application 6.4 North America Ophthalmic Therapeutic Drugs by Company 7 Europe 7.1 Europe Ophthalmic Therapeutic Drugs by Countries 7.1.1 Europe Ophthalmic Therapeutic Drugs Sales by Countries 7.1.2 Europe Ophthalmic Therapeutic Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Ophthalmic Therapeutic Drugs by Type 7.3 Europe Ophthalmic Therapeutic Drugs by Application 7.4 Europe Ophthalmic Therapeutic Drugs by Company 8 Asia Pacific 8.1 Asia Pacific Ophthalmic Therapeutic Drugs by Countries 8.1.1 Asia Pacific Ophthalmic Therapeutic Drugs Sales by Countries 8.1.2 Asia Pacific Ophthalmic Therapeutic Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Ophthalmic Therapeutic Drugs by Type 8.3 Asia Pacific Ophthalmic Therapeutic Drugs by Application 8.4 Asia Pacific Ophthalmic Therapeutic Drugs by Company 9 Central & South America 9.1 Central & South America Ophthalmic Therapeutic Drugs by Countries 9.1.1 Central & South America Ophthalmic Therapeutic Drugs Sales by Countries 9.1.2 Central & South America Ophthalmic Therapeutic Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Ophthalmic Therapeutic Drugs by Type 9.3 Central & South America Ophthalmic Therapeutic Drugs by Application 9.4 Central & South America Ophthalmic Therapeutic Drugs by Company 10 Middle East and Africa 10.1 Middle East and Africa Ophthalmic Therapeutic Drugs by Countries 10.1.1 Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Countries 10.1.2 Middle East and Africa Ophthalmic Therapeutic Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Ophthalmic Therapeutic Drugs by Type 10.3 Middle East and Africa Ophthalmic Therapeutic Drugs by Application 10.4 Middle East and Africa Ophthalmic Therapeutic Drugs by Company 11 Company Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.1.4 Ophthalmic Therapeutic Drugs Product Description 11.1.5 Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.2.4 Ophthalmic Therapeutic Drugs Product Description 11.2.5 Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.3.4 Ophthalmic Therapeutic Drugs Product Description 11.3.5 Recent Development 11.4 ALLERGAN 11.4.1 ALLERGAN Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.4.4 Ophthalmic Therapeutic Drugs Product Description 11.4.5 Recent Development 11.5 Aerie Pharmaceuticals 11.5.1 Aerie Pharmaceuticals Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.5.4 Ophthalmic Therapeutic Drugs Product Description 11.5.5 Recent Development 11.6 Valeant Pharmaceuticals International 11.6.1 Valeant Pharmaceuticals International Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.6.4 Ophthalmic Therapeutic Drugs Product Description 11.6.5 Recent Development 11.7 Genentech 11.7.1 Genentech Company Details 11.7.2 Company Description 11.7.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.7.4 Ophthalmic Therapeutic Drugs Product Description 11.7.5 Recent Development 11.8 Regeneron Pharmaceuticals 11.8.1 Regeneron Pharmaceuticals Company Details 11.8.2 Company Description 11.8.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.8.4 Ophthalmic Therapeutic Drugs Product Description 11.8.5 Recent Development 11.9 Shire 11.9.1 Shire Company Details 11.9.2 Company Description 11.9.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.9.4 Ophthalmic Therapeutic Drugs Product Description 11.9.5 Recent Development 11.10 Santen Pharmaceutical 11.10.1 Santen Pharmaceutical Company Details 11.10.2 Company Description 11.10.3 Sales, Revenue and Gross Margin of Ophthalmic Therapeutic Drugs 11.10.4 Ophthalmic Therapeutic Drugs Product Description 11.10.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Ophthalmic Therapeutic Drugs Raw Material 13.1.2 Ophthalmic Therapeutic Drugs Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer

List of Tables and Figures Figure Picture of Ophthalmic Therapeutic Drugs Figure Global Ophthalmic Therapeutic Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Ophthalmic Therapeutic Drugs Production Market Share by Types (Product Category) in 2017 Figure Anti-inflammatory Drugs Product Picture Table Major Manufacturers of Anti-inflammatory Drugs Figure Anti-infective Drugs Product Picture Table Major Manufacturers of Anti-infective Drugs Figure Anti-glaucoma Drugs Product Picture Table Major Manufacturers of Anti-glaucoma Drugs Figure Anti-allergy Drugs Product Picture Table Major Manufacturers of Anti-allergy Drugs Figure Anti-VEGF Agents Product Picture Table Major Manufacturers of Anti-VEGF Agents Figure Others Product Picture Table Major Manufacturers of Others Table Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Application 2018-2025 (K Units) Figure Hospital Pharmacies Figure Online Pharmacies Figure Independent Pharmacies & Drug Stores Figure Ophthalmic Therapeutic Drugs Report Years Considered Figure Global Ophthalmic Therapeutic Drugs Market Size 2016-2025 (Million US$) Figure Global Ophthalmic Therapeutic Drugs Sales 2016-2025 (K Units) Table Global Ophthalmic Therapeutic Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$) Table Global Ophthalmic Therapeutic Drugs Sales by Regions 2016-2025 (K Units) Table Global Ophthalmic Therapeutic Drugs Sales Market Share by Regions 2016-2025 Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Regions 2016-2025 Figure 2017 Global Ophthalmic Therapeutic Drugs Sales Market Share by Regions Table Global Ophthalmic Therapeutic Drugs Revenue by Regions 2016-2025 (Million US$) Table Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions 2016-2025 Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions 2016-2025 Figure 2017 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions Table Global Ophthalmic Therapeutic Drugs Sales by Manufacturers (2016-2018) (K Units) Table Global Ophthalmic Therapeutic Drugs Sales Share by Manufacturers (2016-2018) Figure Global Ophthalmic Therapeutic Drugs Sales Share by Manufacturers in 2017 Table Ophthalmic Therapeutic Drugs Revenue by Manufacturers (2016-2018) (Million US$) Table Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers (2016-2018) Figure Ophthalmic Therapeutic Drugs Value Share by Manufacturers in 2017 Table Global Ophthalmic Therapeutic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Ophthalmic Therapeutic Drugs Price (2016-2018) (USD/Unit) Table Ophthalmic Therapeutic Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Ophthalmic Therapeutic Drugs Product Category Table Date of International Manufacturers Enter into Ophthalmic Therapeutic Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Ophthalmic Therapeutic Drugs Sales by Type (2016-2025) (K Units) Table Global Ophthalmic Therapeutic Drugs Sales Share by Type (2016-2025) Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2025) Figure Global Ophthalmic Therapeutic Drugs Sales Market Share by Type in 2017 Table Global Ophthalmic Therapeutic Drugs Revenue by Type (2016-2025) (Million US$) Table Global Ophthalmic Therapeutic Drugs Revenue Share by Type (2016-2025) Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2016-2025) Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type in 2017 Table Ophthalmic Therapeutic Drugs Price by Type 2013-2018 (USD/Unit) Table Global Ophthalmic Therapeutic Drugs Sales by Application (2016-2025) (K Units) Table Global Ophthalmic Therapeutic Drugs Sales Share by Application (2016-2025) Figure Global Sales Ophthalmic Therapeutic Drugs Market Share by Application (2016-2025) Figure Global Sales Ophthalmic Therapeutic Drugs Market Share by Application (2016-2025) Figure North America Ophthalmic Therapeutic Drugs Sales Growth Rate 2016-2025 (K Units) Figure North America Ophthalmic Therapeutic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table North America Ophthalmic Therapeutic Drugs Sales by Countries (2016-2025) (K Units) Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 North America Ophthalmic Therapeutic Drugs Sales Market Share by Countries Table North America Ophthalmic Therapeutic Drugs Revenue by Countries (2016-2025) (Million US$) Table North America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 North America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries Figure United States Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure United States Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Canada Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Mexico Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table North America Ophthalmic Therapeutic Drugs Sales by Type (2016-2025) (K Units) Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2025) Figure 2017 North America Ophthalmic Therapeutic Drugs Market Share by Type Table North America Ophthalmic Therapeutic Drugs Sales by Application (2016-2025) (K Units) Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2025) Figure 2017 North America Ophthalmic Therapeutic Drugs Market Share by Application Table North America Ophthalmic Therapeutic Drugs Sales by Company (2016-2018) (K Units) Table North America Ophthalmic Therapeutic Drugs Sales Market Share by Company (2016-2018) Figure North America Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2017 Figure Europe Ophthalmic Therapeutic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Europe Ophthalmic Therapeutic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Europe Ophthalmic Therapeutic Drugs Sales by Countries (2016-2025) (K Units) Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Europe Ophthalmic Therapeutic Drugs Sales Market Share by Countries Table Europe Ophthalmic Therapeutic Drugs Revenue by Countries (2016-2025) (Million US$) Table Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Countries Figure Germany Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Germany Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (K Units) Figure France Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure France Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (K Units) Figure UK Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure UK Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Italy Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Russia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Europe Ophthalmic Therapeutic Drugs Sales by Type (2016-2025) (K Units) Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Europe Ophthalmic Therapeutic Drugs Market Share by Type Table Europe Ophthalmic Therapeutic Drugs Sales by Application (2016-2025) (K Units) Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Europe Ophthalmic Therapeutic Drugs Market Share by Application Table Europe Ophthalmic Therapeutic Drugs Sales by Company (2016-2018) (K Units) Table Europe Ophthalmic Therapeutic Drugs Sales Market Share by Company (2016-2018) Figure Europe Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2017 Figure Asia Pacific Ophthalmic Therapeutic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Asia Pacific Ophthalmic Therapeutic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Countries (2016-2025) (K Units) Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Countries Table Asia Pacific Ophthalmic Therapeutic Drugs Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Ophthalmic Therapeutic Drugs Revenue Market Share by Countries Figure China Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure China Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Japan Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Korea Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure India Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure India Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Australia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Indonesia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Malaysia Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Philippines Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Thailand Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Vietnam Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Singapore Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Type (2016-2025) (K Units) Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Ophthalmic Therapeutic Drugs Market Share by Type Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Application (2016-2025) (K Units) Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Ophthalmic Therapeutic Drugs Market Share by Application Table Asia Pacific Ophthalmic Therapeutic Drugs Sales by Company (2016-2018) (K Units) Table Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Company (2016-2018) Figure Asia Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2017 Figure Central & South America Ophthalmic Therapeutic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Central & South America Ophthalmic Therapeutic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Ophthalmic Therapeutic Drugs Sales by Countries (2016-2025) (K Units) Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Countries Table Central & South America Ophthalmic Therapeutic Drugs Revenue by Countries (2016-2025) (Million US$) Table Central & South America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Ophthalmic Therapeutic Drugs Revenue Market Share by Countries Figure Brazil Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Brazil Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Argentina Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Ophthalmic Therapeutic Drugs Sales by Type (2016-2025) (K Units) Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Ophthalmic Therapeutic Drugs Market Share by Type Table Central & South America Ophthalmic Therapeutic Drugs Sales by Application (2016-2025) (K Units) Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Ophthalmic Therapeutic Drugs Market Share by Application Table Central & South America Ophthalmic Therapeutic Drugs Sales by Company (2016-2018) (K Units) Table Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Company (2016-2018) Figure Central & South America Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2017 Figure Middle East and Africa Ophthalmic Therapeutic Drugs Sales Growth Rate 2016-2025 (K Units) Figure Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Countries (2016-2025) (K Units) Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Countries Table Middle East and Africa Ophthalmic Therapeutic Drugs Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Countries Figure GCC Countries Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure GCC Countries Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Turkey Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure Egypt Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Ophthalmic Therapeutic Drugs Sales Growth Rate (2016-2025) (K Units) Figure South Africa Ophthalmic Therapeutic Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Type (2016-2025) (K Units) Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Market Share by Type Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Application (2016-2025) (K Units) Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Ophthalmic Therapeutic Drugs Market Share by Application Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales by Company (2016-2018) (K Units) Table Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Company (2016-2018) Figure Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Company in 2017 Table Bayer Company Details Table Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Bayer Recent Development Table Pfizer Company Details Table Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Pfizer Recent Development Table Novartis Company Details Table Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Novartis Recent Development Table ALLERGAN Company Details Table ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table ALLERGAN Recent Development Table Aerie Pharmaceuticals Company Details Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Aerie Pharmaceuticals Recent Development Table Valeant Pharmaceuticals International Company Details Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Valeant Pharmaceuticals International Recent Development Table Genentech Company Details Table Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Genentech Recent Development Table Regeneron Pharmaceuticals Company Details Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Regeneron Pharmaceuticals Recent Development Table Shire Company Details Table Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Shire Recent Development Table Santen Pharmaceutical Company Details Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Santen Pharmaceutical Recent Development Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Ophthalmic Therapeutic Drugs Value Chain Table Typical Suppliers of Key Ophthalmic Therapeutic Drugs Raw Material Table Ophthalmic Therapeutic Drugs Customers List Table Ophthalmic Therapeutic Drugs Sales Channels Table Ophthalmic Therapeutic Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources